Roche Diagnostics Australia hosted an information evening dedicated to exploring the current diagnostic tools and management criteria of liver cancer, also known as hepatocellular carcinoma (HCC), in Australia.
Secondary care clinicians (specialists) such as gastroenterologists, hepatologists, and oncologists from across Australia were invited to a thought-provoking HCC surveillance educational event in Melbourne.
In this engaging session, three Australian liver cancer experts shed light on the current standard of care in Australia, HCC surveillance strategies, and blood-based biomarkers to assist in early diagnosis.
Watch the highlight video and full presentation video here.